de Bruin, N.; Schneider, A.-K.; Reus, P.; Talmon, S.; Ciesek, S.; Bojkova, D.; Cinatl, J.; Lodhi, I.; Charlesworth, B.; Sinclair, S.;
et al. Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection. Int. J. Mol. Sci. 2022, 23, 1049.
https://doi.org/10.3390/ijms23031049
AMA Style
de Bruin N, Schneider A-K, Reus P, Talmon S, Ciesek S, Bojkova D, Cinatl J, Lodhi I, Charlesworth B, Sinclair S,
et al. Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection. International Journal of Molecular Sciences. 2022; 23(3):1049.
https://doi.org/10.3390/ijms23031049
Chicago/Turabian Style
de Bruin, Natasja, Ann-Kathrin Schneider, Philipp Reus, Sonja Talmon, Sandra Ciesek, Denisa Bojkova, Jindrich Cinatl, Imran Lodhi, Bruce Charlesworth, Simon Sinclair,
and et al. 2022. "Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection" International Journal of Molecular Sciences 23, no. 3: 1049.
https://doi.org/10.3390/ijms23031049
APA Style
de Bruin, N., Schneider, A. -K., Reus, P., Talmon, S., Ciesek, S., Bojkova, D., Cinatl, J., Lodhi, I., Charlesworth, B., Sinclair, S., Pennick, G., Laughey, W. F., Gribbon, P., Kannt, A., & Schiffmann, S.
(2022). Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection. International Journal of Molecular Sciences, 23(3), 1049.
https://doi.org/10.3390/ijms23031049